Findings from the phase 3 randomized CABASTY clinical trial “may be practice changing,” investigators reported. Biweekly vs triweekly cabazitaxel for mCRPC in men aged 65 years or older has similar efficacy but is associated with a lower risk for neutropenia and/or neutropenic complications.
U.S. and European antitrust enforcers want to unwind gene sequencing leader Illumina Inc's purchase of cancer test company Grail, saying the two would stifle competition in a critical area of... | December 16, 2022
Still, he noted "thoughts about their role being diminished in the future is speculative." Esener, who uses gene sequencing machines from Illumina and Pacific Biosciences of California (PacBio) for research looking to detect liver cancer in its earliest stages, noted the field of early cancer detection is diverse, with about 30 companies working on five different methods of testing for signs of very early cancer – including the types Grail and its rivals are focused on. If proven to work, early cancer detection tests could help doctors identify cancer risk in patients long before symptoms or other indicators develop.
U.S. and European antitrust enforcers want to unwind gene sequencing leader Illumina Inc's purchase of cancer test company Grail, saying the two would stifle competition in a critical area of
By Deena Beasley and Julie Steenhuysen LOS ANGELES/CHICAGO (Reuters) - U.S. and European antitrust enforcers want to unwind gene sequencing leader Ill...
The emotions associated with a breast cancer diagnosis and treatment are sometimes too overwhelming to put into words. When there are no words, many breast cancer patients and survivors opt for pictures instead.